Century Therapeutics Inc (NQ: IPSC )
1.790
+0.040
(+2.29%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Headline News about Century Therapeutics Inc
![](https://cdn.benzinga.com/files/images/story/2024/08/15/Kazan--Russia---Oct-19--2021-Robinhood-M.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/Chem-Lab_3.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Century Therapeutics: Q4 Earnings Insights
March 14, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Recap: Century Therapeutics Q3 Earnings
November 09, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Century Therapeutics: Q1 Earnings Insights
May 11, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_6626.jpeg?width=1200&height=800&fit=crop)
Analyst Ratings for Century Therapeutics
April 13, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://investorplace.com/wp-content/uploads/2020/10/stocks-to-buy-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/01/22/screenshot_2024-01-22_at_6.43.16_pm.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/Russell-2000-Index-magnifying-Glass-Show.jpeg?width=1200&height=800&fit=crop)
Russell 2000 Rallies To 16-Month Highs: Best Performing Small-Cap Stocks Popping Over 80% In December
December 19, 2023
Via Benzinga
Topics
ETFs
![](/next-assets/images/schema-image-default.png)
Century Therapeutics's Return On Capital Employed Overview
March 20, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Where Century Therapeutics Stands With Analysts
March 16, 2023
Via Benzinga
8 Analysts Have This to Say About Century Therapeutics
January 06, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 27, 2022
December 27, 2022
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/08/penny-stocks-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/11/27/screenshot_2023-11-27_at_7.23.33_pm.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
August 28, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/08/28/workday_-_logo.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/08/10/century_therapeutics_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1290.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/19/image19.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_857.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Thursday
January 12, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/10/image29.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2020/03/gene_editing_c_1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/06/group-1.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/20/image15_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_330.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.